vs
Esperion Therapeutics, Inc.（ESPR）与FOSTER L B CO（FSTR）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是FOSTER L B CO的1.1倍（$168.4M vs $160.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 25.1%），过去两年FOSTER L B CO的营收复合增速更高（13.6% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Foster L B Co.是一家总部位于美国的专业工业制造企业，主要生产销售工程通道产品、建筑组件及铁路基础设施用品，服务覆盖北美及部分全球地区的商业建筑、交通和工业领域客户。
ESPR vs FSTR — 直观对比
营收规模更大
ESPR
是对方的1.1倍
$160.4M
营收增速更快
ESPR
高出118.6%
25.1%
两年增速更快
FSTR
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $160.4M |
| 净利润 | — | $2.4M |
| 毛利率 | — | 19.7% |
| 营业利润率 | 50.6% | 4.9% |
| 净利率 | — | 1.5% |
| 营收同比 | 143.7% | 25.1% |
| 净利润同比 | — | 1098.3% |
| 每股收益（稀释后） | $0.32 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRFSTR
| Q4 25 | $168.4M | $160.4M | ||
| Q3 25 | $87.3M | $138.3M | ||
| Q2 25 | $82.4M | $143.6M | ||
| Q1 25 | $65.0M | $97.8M | ||
| Q4 24 | $69.1M | $128.2M | ||
| Q3 24 | $51.6M | $137.5M | ||
| Q2 24 | $73.8M | $140.8M | ||
| Q1 24 | $137.7M | $124.3M |
净利润ESPRFSTR
| Q4 25 | — | $2.4M | ||
| Q3 25 | $-31.3M | $4.4M | ||
| Q2 25 | $-12.7M | $2.9M | ||
| Q1 25 | $-40.5M | $-2.1M | ||
| Q4 24 | — | $-242.0K | ||
| Q3 24 | $-29.5M | $35.9M | ||
| Q2 24 | $-61.9M | $2.8M | ||
| Q1 24 | $61.0M | $4.4M |
毛利率ESPRFSTR
| Q4 25 | — | 19.7% | ||
| Q3 25 | — | 22.5% | ||
| Q2 25 | — | 21.5% | ||
| Q1 25 | — | 20.6% | ||
| Q4 24 | — | 22.3% | ||
| Q3 24 | — | 23.8% | ||
| Q2 24 | — | 21.7% | ||
| Q1 24 | — | 21.1% |
营业利润率ESPRFSTR
| Q4 25 | 50.6% | 4.9% | ||
| Q3 25 | -11.4% | 6.0% | ||
| Q2 25 | 8.6% | 5.3% | ||
| Q1 25 | -34.0% | -2.0% | ||
| Q4 24 | -6.4% | 2.4% | ||
| Q3 24 | -31.0% | 5.3% | ||
| Q2 24 | 3.5% | 3.2% | ||
| Q1 24 | 52.5% | 4.5% |
净利率ESPRFSTR
| Q4 25 | — | 1.5% | ||
| Q3 25 | -35.9% | 3.1% | ||
| Q2 25 | -15.4% | 2.0% | ||
| Q1 25 | -62.2% | -2.2% | ||
| Q4 24 | — | -0.2% | ||
| Q3 24 | -57.2% | 26.1% | ||
| Q2 24 | -83.9% | 2.0% | ||
| Q1 24 | 44.3% | 3.6% |
每股收益（稀释后）ESPRFSTR
| Q4 25 | $0.32 | $0.22 | ||
| Q3 25 | $-0.16 | $0.40 | ||
| Q2 25 | $-0.06 | $0.27 | ||
| Q1 25 | $-0.21 | $-0.20 | ||
| Q4 24 | $-0.14 | $-0.04 | ||
| Q3 24 | $-0.15 | $3.27 | ||
| Q2 24 | $-0.33 | $0.26 | ||
| Q1 24 | $0.34 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $4.3M |
| 总债务越低越好 | — | $42.6M |
| 股东权益账面价值 | $-302.0M | $175.3M |
| 总资产 | $465.9M | $330.4M |
| 负债/权益比越低杠杆越低 | — | 0.24× |
8季度趋势，按日历期对齐
现金及短期投资ESPRFSTR
| Q4 25 | $167.9M | $4.3M | ||
| Q3 25 | $92.4M | $3.4M | ||
| Q2 25 | $86.1M | $4.2M | ||
| Q1 25 | $114.6M | $2.6M | ||
| Q4 24 | $144.8M | $2.5M | ||
| Q3 24 | $144.7M | $3.1M | ||
| Q2 24 | $189.3M | $4.0M | ||
| Q1 24 | $226.6M | $3.1M |
总债务ESPRFSTR
| Q4 25 | — | $42.6M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | — | $81.4M | ||
| Q1 25 | — | $82.3M | ||
| Q4 24 | — | $46.8M | ||
| Q3 24 | — | $68.4M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $77.9M |
股东权益ESPRFSTR
| Q4 25 | $-302.0M | $175.3M | ||
| Q3 25 | $-451.4M | $174.8M | ||
| Q2 25 | $-433.5M | $174.4M | ||
| Q1 25 | $-426.2M | $170.8M | ||
| Q4 24 | $-388.7M | $178.3M | ||
| Q3 24 | $-370.2M | $181.9M | ||
| Q2 24 | $-344.2M | $147.1M | ||
| Q1 24 | $-294.3M | $144.6M |
总资产ESPRFSTR
| Q4 25 | $465.9M | $330.4M | ||
| Q3 25 | $364.0M | $333.9M | ||
| Q2 25 | $347.1M | $349.9M | ||
| Q1 25 | $324.0M | $342.8M | ||
| Q4 24 | $343.8M | $334.6M | ||
| Q3 24 | $314.1M | $344.5M | ||
| Q2 24 | $352.3M | $333.3M | ||
| Q1 24 | $373.1M | $326.4M |
负债/权益比ESPRFSTR
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.38× | ||
| Q2 24 | — | 0.59× | ||
| Q1 24 | — | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $19.8M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | 0.0% | 1.5% |
| 现金转化率经营现金流/净利润 | — | 9.18× |
| 过去12个月自由现金流最近4个季度 | — | $25.2M |
8季度趋势，按日历期对齐
经营现金流ESPRFSTR
| Q4 25 | $45.2M | $22.2M | ||
| Q3 25 | $-4.3M | $29.2M | ||
| Q2 25 | $-31.4M | $10.4M | ||
| Q1 25 | $-22.6M | $-26.1M | ||
| Q4 24 | $-35.0M | $24.3M | ||
| Q3 24 | $-35.3M | $24.7M | ||
| Q2 24 | $-7.2M | $-5.0M | ||
| Q1 24 | $53.8M | $-21.4M |
自由现金流ESPRFSTR
| Q4 25 | — | $19.8M | ||
| Q3 25 | — | $26.4M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $-28.7M | ||
| Q4 24 | — | $22.3M | ||
| Q3 24 | $-35.5M | $21.7M | ||
| Q2 24 | $-7.3M | $-7.0M | ||
| Q1 24 | $53.8M | $-24.2M |
自由现金流率ESPRFSTR
| Q4 25 | — | 12.3% | ||
| Q3 25 | — | 19.1% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -29.4% | ||
| Q4 24 | — | 17.4% | ||
| Q3 24 | -68.7% | 15.8% | ||
| Q2 24 | -9.9% | -5.0% | ||
| Q1 24 | 39.0% | -19.4% |
资本支出强度ESPRFSTR
| Q4 25 | 0.0% | 1.5% | ||
| Q3 25 | 0.0% | 2.0% | ||
| Q2 25 | 0.0% | 1.9% | ||
| Q1 25 | 0.0% | 2.6% | ||
| Q4 24 | 0.0% | 1.5% | ||
| Q3 24 | 0.3% | 2.2% | ||
| Q2 24 | 0.1% | 1.5% | ||
| Q1 24 | 0.1% | 2.2% |
现金转化率ESPRFSTR
| Q4 25 | — | 9.18× | ||
| Q3 25 | — | 6.70× | ||
| Q2 25 | — | 3.61× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.69× | ||
| Q2 24 | — | -1.74× | ||
| Q1 24 | 0.88× | -4.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FSTR
| Rail Technologies And Services Segment | $98.0M | 61% |
| Over Time Output Method | $26.3M | 16% |
| Services | $19.4M | 12% |
| Rail Technologies Products | $10.0M | 6% |
| Over Time Input Method | $8.3M | 5% |
